AIDS WEEKLY Plus - February 2008Important note: Information in this article was accurate in February 2008. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

DonateNow
Print this Article

HIV/AIDS Prevention: New HIV/AIDS prevention data have been reported by P.A. Clark and co-authors

AIDSWEEKLY Plus; Monday, February 11, 2008
Staff Medical Writers


NewsRx -- Fresh data on HIV/AIDS are presented in the report 'Mandatory neonatal male circumcision in Sub-Saharan Africa: medical and ethical analysis.' According to recent research from the United States, "The majority of those infected with HIV in sub-Saharan Africa do not have access to antiretroviral therapy, which is known to prolong the lives of HIV-positive persons in industrialized countries (see also HIV/AIDS Prevention). Although the availability of antiretroviral therapy for those infected with HIV has increased worldwide, the infection rate out surpasses those started on such treatment."

"Without an AIDS vaccine or curative treatment, and given the difficulty in getting persons at risk to adopt healthy sexual behaviors, alternative approaches to decrease the spread of HIV infection are urgently needed. Three recent randomized controlled trials undertaken in Kisumu, Kenya, Raki District, Uganda and Orange Farm, South Africa have confirmed that male circumcision reduces the risk of heterosexually acquired HIV infection in men by approximately 51% to 60%. These three studies provide a solid evidence-base for future health policy. The procedure for adolescents and adults is expensive compared to abstinence, condoms or other methods; and the surgery is not without serious risks if performed by traditional healers using unsterilized blades as often happens in rural Africa. However, neonatally, the procedure is relatively inexpensive and the risks diminish considerably. Mandating neonatal male circumcision is an effective therapy that has minimal risks, is cost efficient and will save human lives. To deny individuals access to this effective therapy is to deny them the dignity and respect all persons deserve," wrote P.A. Clark and colleagues, .

The researchers concluded: "Neonatal male circumcision is medically necessary and ethically imperative."

Clark and colleagues published their study in Medical Science Monitor (Mandatory neonatal male circumcision in Sub-Saharan Africa: medical and ethical analysis. Med Sci Monit. 2007 Dec;13(12):RA205-13).

For additional information, contact P.A. Clark, Institute of Catholic Bioethics, St. Joseph's University, Philadelphia, PA 19131 USA..

Publisher contact information for the journal Medical Science Monitor is: International Scientific Literature, Inc., 1125 Willis Avenue, Albertson, NY 11507, USA.

Keywords: United States, Philadelphia, HIV/AIDS Prevention, AIDS, Acquired Immunodeficiency Syndrome, Antivirals, Behavior, Biotechnology, Circumcision, Clinical Trial Research, HIV, Human Immunodeficiency Virus, Immunization, Surgery, Therapy, Treatment, Vaccines, Virology.

This article was prepared by AIDS Weekly editors from staff and other reports.

2008-02-11
AW080205


Copyright © 2008 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.